At the 17th Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco—Tim Horn speaks with David Hardy, MD, from Cedars Sinai Medical Center in Los Angeles, about new HIV treatments—including the drug blood level-booster, cobicistat, and the new integrase inhibitor, elvitegravir. Part 1 of a 2-part video.


7 minutes. Transcript Coming Soon.